CMA Wins Drug Price Appeal But £100M Fines Face Review
An appeals court upheld on Tuesday findings by a competition tribunal that a group of pharmaceutical companies abused its dominant position to overcharge for a life-saving adrenal drug, but sent approximately...To view the full article, register now.
Already a subscriber? Click here to view full article